Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.

Muller K, Naus N, Nowak PJ, Schmitz PI, de Pan C, van Santen CA, Marijnissen JP, Paridaens DA, Levendag PC, Luyten GP.

Radiother Oncol. 2012 Feb;102(2):219-24. doi: 10.1016/j.radonc.2011.06.038. Epub 2011 Aug 22.

PMID:
21864922
2.

Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence?

Oosten AW, Oldenmenger WH, van Zuylen C, Schmitz PI, Bannink M, Lieverse PJ, Bromberg JE, van der Rijt CC.

Eur J Cancer. 2011 Oct;47(15):2341-6. doi: 10.1016/j.ejca.2011.06.057. Epub 2011 Jul 26.

3.

Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial.

Hamberg P, Bos MM, Braun HJ, Stouthard JM, van Deijk GA, Erdkamp FL, van der Stelt-Frissen IN, Bontenbal M, Creemers GJ, Portielje JE, Pruijt JF, Loosveld OJ, Smit WM, Muller EW, Schmitz PI, Seynaeve C, Klijn JG; Dutch Breast Cancer Trialists' Group (BOOG).

Clin Breast Cancer. 2011 Apr;11(2):103-13. doi: 10.1016/j.clbc.2011.03.003. Epub 2011 Apr 11.

PMID:
21569996
4.

Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.

van der Ploeg AP, van Akkooi AC, Schmitz PI, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C.

Ann Surg Oncol. 2011 Nov;18(12):3300-8. doi: 10.1245/s10434-011-1741-0. Epub 2011 May 3.

5.

Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time.

de Graaf MT, van den Broek PD, Kraan J, Luitwieler RL, van den Bent MJ, Boonstra JG, Schmitz PI, Gratama JW, Sillevis Smitt PA.

J Neurol. 2011 Aug;258(8):1507-12. doi: 10.1007/s00415-011-5970-8. Epub 2011 Mar 12.

6.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, Peterse H, Tollenaar RA, Hoogerbrugge N, Meijer S, Bartels CC, Seynaeve C, Hooning MJ, Kriege M, Schmitz PI, Oosterwijk JC, de Koning HJ, Rutgers EJ, Klijn JG.

J Clin Oncol. 2010 Dec 20;28(36):5265-73. doi: 10.1200/JCO.2009.27.2294. Epub 2010 Nov 15.

PMID:
21079137
7.

Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors.

van Geel AN, Wouters MW, Lans TE, Schmitz PI, Verhoef C.

World J Surg. 2011 Jan;35(1):63-9. doi: 10.1007/s00268-010-0804-x.

8.

EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.

van der Ploeg AP, van Akkooi AC, Schmitz PI, Koljenovic S, Verhoef C, Eggermont AM.

Eur J Cancer. 2010 Sep;46(13):2414-21. doi: 10.1016/j.ejca.2010.06.003.

PMID:
20621467
9.

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.

Surmont V, Aerts JG, van Klaveren RJ, Tournoy K, Tan KY, Vernhout RM, Schmitz PI, Legrand C, Hoogsteden HC, van Meerbeeck JP.

Oncology. 2010;78(3-4):267-70. doi: 10.1159/000315733. Epub 2010 Jun 7.

PMID:
20523087
10.

Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel.

Strijbos MH, Gratama JW, Schmitz PI, Rao C, Onstenk W, Doyle GV, Miller MC, de Wit R, Terstappen LW, Sleijfer S.

Eur J Cancer. 2010 Jul;46(11):2027-35. doi: 10.1016/j.ejca.2010.03.030.

PMID:
20399640
11.

Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin.

Oosten AW, Seynaeve C, Schmitz PI, den Bakker MA, Verweij J, Sleijfer S.

Sarcoma. 2009;2009:348910. doi: 10.1155/2009/348910. Epub 2009 Dec 29.

12.

Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?

Voit CA, van Akkooi AC, Schäfer-Hesterberg G, Schoengen A, Schmitz PI, Sterry W, Eggermont AM.

J Clin Oncol. 2009 Oct 20;27(30):4994-5000. doi: 10.1200/JCO.2008.19.0033. Epub 2009 Sep 8.

PMID:
19738131
13.

Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence.

van der Pol CC, van Geel AN, Menke-Pluymers MB, Schmitz PI, Lans TE.

Ann Surg Oncol. 2009 Dec;16(12):3414-21. doi: 10.1245/s10434-009-0662-7.

14.

Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer.

Teguh DN, Levendag PC, Noever I, Voet P, van der Est H, van Rooij P, Dumans AG, de Boer MF, van der Huls MP, Sterk W, Schmitz PI.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):711-6. doi: 10.1016/j.ijrobp.2008.11.056. Epub 2009 Apr 20.

PMID:
19386439
15.

Complications in wound healing after chest wall resection in cancer patients; a multivariate analysis of 220 patients.

Lans TE, van der Pol C, Wouters MW, Schmitz PI, van Geel AN.

J Thorac Oncol. 2009 May;4(5):639-43. doi: 10.1097/JTO.0b013e31819d18c9.

16.

Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.

Swaak-Kragten AT, de Wilt JH, Schmitz PI, Bontenbal M, Levendag PC.

Radiother Oncol. 2009 Jul;92(1):100-4. doi: 10.1016/j.radonc.2009.02.016. Epub 2009 Mar 26.

PMID:
19328572
17.

Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.

Surmont V, Aerts JG, Pouw E, Tan KY, Vernhout R, Gras J, Salomé J, Pronk T, Schmitz PI, Hoogsteden H, van Klaveren RJ.

Lung Cancer. 2009 Dec;66(3):333-7. doi: 10.1016/j.lungcan.2009.02.016. Epub 2009 Mar 26.

PMID:
19327865
18.

Incisional hernia after upper abdominal surgery: a randomised controlled trial of midline versus transverse incision.

Halm JA, Lip H, Schmitz PI, Jeekel J.

Hernia. 2009 Jun;13(3):275-80. doi: 10.1007/s10029-008-0469-7. Epub 2009 Mar 4.

19.

Chest wall resection for internal mammary lymph node metastases of breast cancer.

van Geel AN, Wouters MW, van der Pol C, Schmitz PI, Lans T.

Breast. 2009 Apr;18(2):94-9. doi: 10.1016/j.breast.2009.01.005. Epub 2009 Feb 24.

PMID:
19243947
20.

Quality of life of oropharyngeal cancer patients treated with brachytherapy.

Teguh DN, Levendag PC, Kolkman-Deurloo IK, van Rooij P, Schmitz PI.

Curr Oncol Rep. 2009 Mar;11(2):143-50. Review.

PMID:
19216846
21.

Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage.

Strijbos MH, Rao C, Schmitz PI, Kraan J, Lamers CH, Sleijfer S, Terstappen LW, Gratama JW.

Thromb Haemost. 2008 Oct;100(4):642-7.

PMID:
18841287
22.

Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery.

Nijdam WM, Levendag PC, Noever I, Schmitz PI, Uyl-de Groot CA.

Brachytherapy. 2008 Oct-Dec;7(4):343-50. doi: 10.1016/j.brachy.2008.05.001. Epub 2008 Sep 10.

PMID:
18786864
23.

Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.

Teguh DN, Levendag PC, Sewnaik A, Hakkesteegt MM, Noever I, Voet P, van der Est H, Sipkema D, van Rooij P, Baatenburg de Jong RJ, Schmitz PI.

Radiother Oncol. 2008 Oct;89(1):57-63. doi: 10.1016/j.radonc.2008.07.012. Epub 2008 Aug 20.

PMID:
18722028
24.

Factors Influencing Prognosis After Initial Inadequate Excision (IIE) for Soft Tissue Sarcoma.

Van Geel AN, Eggermont AM, Hanssens PE, Schmitz PI.

Sarcoma. 2003;7(3-4):159-65. doi: 10.1080/13577140310001650321.

25.

Which Soft Tissue Sarcoma Patients with Lung Metastases Should not Undergo Pulmonary Resection?

van Geel AN, Rm van Der Sijp J, Schmitz PI.

Sarcoma. 2002;6(2):57-60. doi: 10.1155/S1357714X02000178.

26.

Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.

Teguh DN, Levendag PC, Noever I, van Rooij P, Voet P, van der Est H, Sipkema D, Sewnaik A, Baatenburg de Jong RJ, de la Bije D, Schmitz PI.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1119-27. doi: 10.1016/j.ijrobp.2008.02.061. Epub 2008 May 28.

PMID:
18472364
27.

Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.

Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de Kruijf W, van Rooij P, Schmitz PI, Heijmen BJ.

Head Neck. 2008 May;30(5):622-30. doi: 10.1002/hed.20760.

PMID:
18213726
28.

Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences.

Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, Haxer M, Noever I, Chepeha DB, Heijmen BJ.

Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S40-2.

29.

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ, Kolkman-Deurloo IK, Prevost JB, Poll J, Schmitz PI, Heijmen BJ.

Radiother Oncol. 2007 Oct;85(1):64-73. Epub 2007 Aug 21.

PMID:
17714815
30.

Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.

van Akkooi AC, Bouwhuis MG, de Wilt JH, Kliffen M, Schmitz PI, Eggermont AM.

Br J Surg. 2007 Oct;94(10):1293-9.

PMID:
17702089
31.

Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.

van Akkooi AC, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C, Grunhagen DJ, Schmitz PI, Eggermont AM, de Wilt JH.

Eur J Surg Oncol. 2007 Feb;33(1):102-8. Epub 2006 Dec 11.

PMID:
17161577
32.

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PI, van Geel AN, Eggermont AM, Kliffen M.

Ann Oncol. 2006 Oct;17(10):1578-85. Epub 2006 Sep 12.

PMID:
16968875
33.
34.

Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.

Garssen MP, Schmitz PI, Merkies IS, Jacobs BC, van der Meché FG, van Doorn PA.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):61-5.

35.

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre.

Bontenbal M, Creemers GJ, Braun HJ, de Boer AC, Janssen JT, Leys RB, Ruit JB, Goey SH, van der Velden PC, Kerkhofs LG, Schothorst KL, Schmitz PI, Bokma HJ, Verweij J, Seynaeve C; Dutch Community Setting Trial for the Clinical Trial Group.

J Clin Oncol. 2005 Oct 1;23(28):7081-8.

PMID:
16192591
36.

Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial.

van Tongeren RB, van Sambeek MR, van Overhagen H, Coen VL, Schmitz PI, Gescher FM, Wittens CH, Vernhout RM, van Urk H, Levendag PC, Bruijninckx CM.

J Cardiovasc Surg (Torino). 2005 Aug;46(4):437-43.

PMID:
16160691
37.

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA.

Neurology. 2004 Dec 28;63(12):2393-5.

PMID:
15623709
38.

Sensory exam with a quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude.

Merkies IS, Schmitz PI, van Doorn PA.

Neurology. 2004 Sep 28;63(6):1138; author reply 1138. No abstract available.

PMID:
15452325
39.

Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood.

Arts WF, Brouwer OF, Peters AC, Stroink H, Peeters EA, Schmitz PI, van Donselaar CA, Geerts AT.

Brain. 2004 Aug;127(Pt 8):1774-84. Epub 2004 Jun 16.

PMID:
15201192
40.

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.

van Koningsveld R, Schmitz PI, Meché FG, Visser LH, Meulstee J, van Doorn PA; Dutch GBS study group.

Lancet. 2004 Jan 17;363(9404):192-6.

PMID:
14738791
41.

External beam radiation therapy to prevent anastomotic intimal hyperplasia in prosthetic arteriovenous fistulas: results of a randomized trial.

van Tongeren RB, Levendag PC, Coen VL, Schmitz PI, Gescher FM, Vernhout RM, Wittens CH, Bruijninckx CM.

Radiother Oncol. 2003 Oct;69(1):73-7.

PMID:
14597359
42.

Comparison between impairment and disability scales in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, Van Der Meché FG, Van Doorn PA.

Muscle Nerve. 2003 Jul;28(1):93-100.

PMID:
12811779
43.

Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function.

Braaksma MM, Wijers OB, van Sörnsen de Koste JR, van der Est H, Schmitz PI, Nowak PJ, Levendag PC.

Radiother Oncol. 2003 Mar;66(3):291-302.

PMID:
12742269
44.

Mastectomy by inverted drip incision and immediate reconstruction: data from 510 cases.

Van Geel AN, Contant CM, Wai RT, Schmitz PI, Eggermont AM, Menke-Pluijmers MM.

Ann Surg Oncol. 2003 May;10(4):389-95.

PMID:
12734087
45.

Connecting impairment, disability, and handicap in immune mediated polyneuropathies.

Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):99-104.

46.

A clinical evaluation of implants in irradiated oral cancer patients.

Visch LL, van Waas MA, Schmitz PI, Levendag PC.

J Dent Res. 2002 Dec;81(12):856-9.

PMID:
12454102
47.

Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.

Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI.

Head Neck. 2002 Aug;24(8):737-47.

PMID:
12203798
48.

Long-term impact on work and private life after Guillain-Barré syndrome.

Bernsen RA, de Jager AE, Schmitz PI, van der Meché FG.

J Neurol Sci. 2002 Sep 15;201(1-2):13-17.

PMID:
12163188
49.

Quality of life complements traditional outcome measures in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) group.

Neurology. 2002 Jul 9;59(1):84-91.

PMID:
12105312
50.

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) group.

J Neurol Neurosurg Psychiatry. 2002 May;72(5):596-601.

Supplemental Content

Loading ...
Support Center